Campbell & CO Investment Adviser LLC Akebia Therapeutics, Inc. Transaction History

Campbell & CO Investment Adviser LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 10, 2019	SELL	$4.1 - $8.05 $80,011 - $157,095	-19,515 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$5.41 - $8.73 $105,576 - $170,365	19,515 New	19,515 $160,000
Q1 2018 May 04, 2018	SELL	$9.53 - $15.68 $96,014 - $157,976	-10,075 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$14.24 - $19.59 $1,395 - $1,919	-98 Reduced 0.96%	10,075 $150,000
Q3 2017 Nov 13, 2017	BUY	$13.06 - $19.67 $132,859 - $200,102	10,173	10,173 $200,000

128

63.3M

50.6K

203K

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $368M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.